ARMAND GALLANOSA: Open Payments
NPI 1861446387 · ANDERSON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,595 in 139 payments from 22 companies in 2025. Trend: 2023 $2,310 · 2024 $3,027 · 2025 $2,595
Food & beverage: $2,563Education: $32
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $365 |
| ABBVIE INC. | 16 | $294 |
| PFIZER INC. | 22 | $288 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $249 |
| Axsome Therapeutics, Inc. | 9 | $226 |
| Lundbeck LLC | 10 | $180 |
| Phathom Pharmaceuticals, Inc. | 6 | $169 |
| AstraZeneca Pharmaceuticals LP | 7 | $161 |
| Lilly USA, LLC | 6 | $114 |
| Otsuka America Pharmaceutical, Inc. | 5 | $93 |
Products named: REXULTI, Kerendia, Ozempic, Auvelity, VOQUEZNA, NURTEC ODT, QULIPTA, VRAYLAR.
Industry payments across IN — which companies pay providers there.
